Literature DB >> 22398308

Allergen-specific responses of CD19(+)CD5(+)Foxp3(+) regulatory B cells (Bregs) and CD4(+)Foxp3(+) regulatory T cell (Tregs) in immune tolerance of cow milk allergy of late eczematous reactions.

Joonyong Noh1, Geunwoong Noh, Hyuk Soon Kim, A-Ram Kim, Wahn Soo Choi.   

Abstract

Foxp3-expressing cells among CD19(+)CD5(+) B cells were identified as regulatory B cells. Food allergy manifesting as late eczematous reactions is regarded as a non-IgE-mediated food allergy. The diagnosis for milk allergy manifesting as late eczematous reactions was made on the basis of the findings obtained from a double-blind placebo-controlled food challenge in patients with atopic dermatitis. Twelve patients with milk allergy and 12 patients who could tolerate milk were selected. On casein stimulation, the CD19(+)CD5(+)Foxp3(+) B cell (Breg) fraction in CD5(+) B cells decreased from 4.4±1.1% to 3.1±0.7% (P=0.047, n=12) in the milk allergy group and increased from 4.4±1.3% to 5.2±1.4% (P=0.001, n=10) in the milk-tolerant group. On the other hand, on allergen stimulation, the number of CD4(+)Foxp3(+) regulatory T cells (Tregs) in the milk allergy group and milk-tolerant group increased from 2.6±0.7% to 3.4±0.6% (P=0.014, n=9) and from 2.7±1.0% to 3.5±1.0% (P=0.038, n=10), respectively. In conclusion, allergen-specific responses of Bregs, rather than those of Tregs, seem to influence the immune responses (i.e., allergy or tolerance) to a food allergen.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22398308     DOI: 10.1016/j.cellimm.2012.01.005

Source DB:  PubMed          Journal:  Cell Immunol        ISSN: 0008-8749            Impact factor:   4.868


  20 in total

1.  Pathways to managing atopic dermatitis: consensus from the experts.

Authors:  Mark G Lebwohl; James Q Del Rosso; William Abramovits; Brian Berman; David E Cohen; Emma Guttman; Anthony J Mancini; Lawrence A Schachner
Journal:  J Clin Aesthet Dermatol       Date:  2013-07

Review 2.  The regulation of immune tolerance by FOXP3.

Authors:  Ling Lu; Joseph Barbi; Fan Pan
Journal:  Nat Rev Immunol       Date:  2017-07-31       Impact factor: 53.106

3.  Changes in peripheral CD19(+)Foxp3(+) and CD19(+)TGFβ(+) regulatory B cell populations in rheumatoid arthritis patients with interstitial lung disease.

Authors:  Yingying Guo; Xiaomei Zhang; Muting Qin; Xiaofei Wang
Journal:  J Thorac Dis       Date:  2015-03       Impact factor: 2.895

4.  Use of Toll-Like Receptor (TLR) Ligation to Characterize Human Regulatory B-Cells Subsets.

Authors:  Mathilde A M Chayé; Chiara Tontini; Arifa Ozir-Fazalalikhan; Astrid L Voskamp; Hermelijn H Smits
Journal:  Methods Mol Biol       Date:  2021

5.  Regulatory and IgE+ B Cells in Allergic Asthma.

Authors:  John Paul Oliveria; Rita Agayby; Gail M Gauvreau
Journal:  Methods Mol Biol       Date:  2021

Review 6.  Mechanisms of tolerance induction in allergic disease: integrating current and emerging concepts.

Authors:  J Wisniewski; R Agrawal; J A Woodfolk
Journal:  Clin Exp Allergy       Date:  2013-02       Impact factor: 5.018

Review 7.  FoxP3 Expression in Macrophages, Cancer, and B Cells-Is It Real?

Authors:  Zahava Vadasz; Elias Toubi
Journal:  Clin Rev Allergy Immunol       Date:  2017-06       Impact factor: 8.667

8.  Regulatory B cells and T follicular helper cells are reduced in allergic rhinitis.

Authors:  Alexander S Kim; Taylor A Doherty; Maya R Karta; Sudipta Das; Rachel Baum; Peter Rosenthal; Andrew Beppu; Marina Miller; Richard Kurten; David H Broide
Journal:  J Allergy Clin Immunol       Date:  2016-04-06       Impact factor: 10.793

Review 9.  The Role of Regulatory B cells in Kidney Diseases.

Authors:  Wang Long; Hedong Zhang; Wenjia Yuan; Gongbin Lan; Zhi Lin; Longkai Peng; Helong Dai
Journal:  Front Immunol       Date:  2021-05-24       Impact factor: 7.561

Review 10.  B cells and food allergy.

Authors:  Chioma Udemgba; Adora Lin
Journal:  Curr Opin Pediatr       Date:  2021-12-01       Impact factor: 2.856

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.